Austria
· Delayed Price · Currency is EUR Marinomed Biotech AG Statistics
Total Valuation
VIE:MARI has a market cap or net worth of EUR 25.25 million. The enterprise value is 53.43 million.
| Market Cap | 25.25M |
| Enterprise Value | 53.43M |
Important Dates
The next estimated earnings date is Wednesday, April 16, 2025.
| Earnings Date | Apr 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VIE:MARI has 1.78 million shares outstanding. The number of shares has decreased by -0.40% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.78M |
| Shares Change (YoY) | -0.40% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 29.54% |
| Owned by Institutions (%) | 26.20% |
| Float | 1.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.36 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.78 |
| EV / Sales | 8.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.88 |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.01 |
| Interest Coverage | -1.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -26.77% |
| Return on Invested Capital (ROIC) | -33.81% |
| Return on Capital Employed (ROCE) | 40.45% |
| Revenue Per Employee | 145,884 |
| Profits Per Employee | -320,848 |
| Employee Count | 52 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 5.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.07% in the last 52 weeks. The beta is -0.14, so VIE:MARI's price volatility has been lower than the market average.
| Beta (5Y) | -0.14 |
| 52-Week Price Change | -36.07% |
| 50-Day Moving Average | 14.10 |
| 200-Day Moving Average | 11.38 |
| Relative Strength Index (RSI) | 53.67 |
| Average Volume (20 Days) | 1,482 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VIE:MARI had revenue of EUR 6.42 million and -14.12 million in losses. Loss per share was -9.33.
| Revenue | 6.42M |
| Gross Profit | 745,400 |
| Operating Income | -6.25M |
| Pretax Income | -14.11M |
| Net Income | -14.12M |
| EBITDA | -5.86M |
| EBIT | -6.25M |
| Loss Per Share | -9.33 |
Balance Sheet
The company has 911,500 in cash and 29.09 million in debt, giving a net cash position of -28.18 million or -15.85 per share.
| Cash & Cash Equivalents | 911,500 |
| Total Debt | 29.09M |
| Net Cash | -28.18M |
| Net Cash Per Share | -15.85 |
| Equity (Book Value) | -20.55M |
| Book Value Per Share | -13.34 |
| Working Capital | -22.58M |
Cash Flow
In the last 12 months, operating cash flow was -4.14 million and capital expenditures -4,900, giving a free cash flow of -4.15 million.
| Operating Cash Flow | -4.14M |
| Capital Expenditures | -4,900 |
| Free Cash Flow | -4.15M |
| FCF Per Share | -2.33 |
Margins
Gross margin is 11.61%, with operating and profit margins of -97.29% and -219.93%.
| Gross Margin | 11.61% |
| Operating Margin | -97.29% |
| Pretax Margin | -219.87% |
| Profit Margin | -219.93% |
| EBITDA Margin | -91.25% |
| EBIT Margin | -97.29% |
| FCF Margin | n/a |
Dividends & Yields
VIE:MARI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.40% |
| Shareholder Yield | 0.40% |
| Earnings Yield | -55.90% |
| FCF Yield | -16.43% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VIE:MARI has an Altman Z-Score of -11.13. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.13 |
| Piotroski F-Score | n/a |